oleanolic acid has been researched along with Hepatitis C in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, MC; Huang, YH; Lan, KH; Lan, KL; Lee, WP; Liao, SX | 1 |
Akahori, Y; Hasegawa, H; Hijikata, M; Nio, Y; Okamura, H; Oshima, M; Ryo, A; Sasai, M; Tanaka, Y; Wakita, T; Watashi, K | 1 |
Fang, X; Kong, L; Li, S; Liao, Q; Sun, R; Wang, J; Wu, X; Zhang, Q; Zhang, Y; Zhu, X; Zhu, Y | 1 |
Chang, SP; Chung, CY; Hsu, WC; Hung, TC; Li, CF; Lin, CC; Lin, LT; Richardson, CD; Russell, RS; Shields, J; Tyrrell, DL; Yen, MH | 1 |
Kumada, H; Tsubota, A | 1 |
Iwabuchi, S; Osada, T; Takatori, M; Yoshida, H | 1 |
2 review(s) available for oleanolic acid and Hepatitis C
Article | Year |
---|---|
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
Topics: Biomarkers; Cysteine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Middle Aged; Oleanolic Acid; RNA, Viral | 1994 |
4 other study(ies) available for oleanolic acid and Hepatitis C
Article | Year |
---|---|
Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus.
Topics: Antiviral Agents; Carbamates; Cells, Cultured; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Imidazoles; Oleanolic Acid; Pyrrolidines; Saponins; Valine; Viral Nonstructural Proteins; Virus Replication | 2019 |
Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Coinfection; DNA, Viral; Heme Oxygenase-1; Hep G2 Cells; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatocytes; Humans; NF-E2-Related Factor 2; Oleanolic Acid; Virus Replication | 2019 |
Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity.
Topics: Antiviral Agents; Cell Line; Down-Regulation; Drugs, Chinese Herbal; Hepacivirus; Hepatitis C; Humans; Ligustrum; Oleanolic Acid; Replicon; Triterpenes; Ursolic Acid; Viral Nonstructural Proteins; Virus Replication | 2013 |
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Topics: Animals; Antiviral Agents; Bupleurum; Cell Line; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Liver Transplantation; Male; Oleanolic Acid; Plant Extracts; Rats; Rats, Sprague-Dawley; Saponins; Virion; Virus Internalization; Virus Replication | 2015 |